MONTREAL, May 15 /CNW Telbec/ - Haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, announced today the appointment of Reinaldo M. Diaz as a new member of the Board of Directors’ of the Company.
